Call 800 665 0411 to learn about our services

Search   Follow Investorideas on Twitter   Investorideas is on Facebook   Investorideas is on Youtube   Investorideas is on Pinterest  Investorideas is on stocktwits   Investorideas is on tumblr   Investorideas is on LinkedIn   Investorideas Instagram   Investorideas Telegram   Investorideas Gettr   Investorideas RSS

Share on StockTwits

Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move; TSX: $ACB.TO, TSXV: $ICC.V, CSE: $LILY.C, TSX: $HEXO.TO

Global medical cannabis market was valued US$ 3.52 Billion in 2017 podcasts


Pt. Roberts, WA; Delta, BC - June 26, 2018 ( Newswire), a global news source covering leading sectors including marijuana and hemp stocks and its "potcast" site, release today's edition of its series, potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move; TSX: ACB, TSXV: ICC, CSE: LILY, TSX: HEXO

Today's podcast overview/transcript:

Good afternoon and welcome to another potcast ; looking at cannabis news, stocks to watch as well as insights from thought leaders and experts. Today's podcast features news announcements from Aurora Cannabis Inc. trading (TSX: ACB and OTCQB:ACBFF) , ICC Labs Inc ( TSX-Venture: ICC) , Callitas ( CSE: LILY and OTCQB: MPHMF) and The Hydropothecary Corporation ( TSX: HEXO).

But first, according to Coherent Market Insights the global medical cannabis market was valued US$ 3.52 Billion in 2017 and is projected to exhibit a compound annual growth rate of 24.4% over the forecast period of 2017 - 2025.

The Cannabidiol (CBD) segment is expected to gain significant traction over the forecast period, on account of the continuous engagement of manufacturers to introduce Hemp Cannabidiol products in various forms

Among therapeutic application, pain segment accounted for the largest market share, owing to increase in government initiatives to enable patients to use medicinal marijuana, as a treatment in chronic pain management

Some of the major players operating in the global medical cannabis market include BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc., Canopy Growth Corporation, Insys Therapeutics, Inc., Aphria, Inc., MGC Pharmaceuticals Limited, GW Pharmaceuticals, plc, and Medical Marijuana Inc.

Aurora Cannabis Inc. announced today that it has agreed to a new $200 million debt facility, with a potential upsize to $250 million, with the Bank of Montreal ("BMO").

The facility will consist of a $150 million term loan and a $50 million revolving credit facility, both of which will mature in 2021. A short period after the implementation of Bill C-45 in October 2018, the Company may request an increase of up to a further $45 million to the term loan subject to agreement by BMO and satisfaction of certain legal and business conditions. BMO will also be providing up to $5 million in other credit instruments. Closing of the debt facility is subject to completion of final due diligence, negotiation of definitive documentation, and satisfaction of conditions precedent customary to a financing of this nature.

The debt facility will be primarily secured by Aurora's production facilities, including Aurora Sky, Aurora Mountain, and Aurora Vie. Strategically located at Edmonton International Airport, Aurora Sky is the world's most technologically advanced cannabis facility, projected to produce in excess of 100,000 kg per year of high-quality cannabis at low per gram costs, and slated to deliver its first harvest this week.

ICC Labs Inc. announced that the Government of Uruguay through its regulatory authority IRCCA (Cannabis Regulation and Control Institute) has granted the Company an additional land package of approximately 55,000 square foot in order to increase its production capacity.

“A relevant milestone that demonstrates the confidence that the Government has placed in our Company to continue executing the terms of our recreational cannabis license granted for 5 years on January 14, 2016,” commented Alejandro Antalich, Chief Executive Officer of ICC Labs.

Callitas, an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, announced today that it has entered into a non-exclusive licensing and technology agreement with LifeStyles, LTD, the global leader in the sexual wellness sector, for its non-branded, patented arousal gel and lubricants for use on condoms and as a stand-alone product for retail and consumer markets around the world. 

“Partnering of Callitas' non-branded products and technologies to reach new markets and sales channels is a critical component of our business model,” said James M. Thompson, President and CEO. “Partnering with the worldwide leader in sexual wellness, Lifestyles, LTD., is an outstanding way to expand our sales as we look forward to a long-term, mutually beneficial future.”

Under the terms of the agreement, Callitas will receive a variable, single-digit royalty on net sales of all products sold worldwide by Lifestyles, LTD., on any of their brands. Callitas will also assist LifeStyles, LTD., in the development of additional sexual health and wellness retail consumer goods.

Finally, the Hydropothecary Corporation, HEXO, announced that four zones of its 250,000 sq. ft. greenhouse expansion are now licensed by Health Canada.

The licensing of two additional zones aligns with HEXO's continual harvest methodology, which splits the greenhouse into zones that can be tailored to each stage of plant growth.

“Four of ten zones now have plants in and are fully operational, the other zones will follow in the coming weeks, with all 10 zones set to be operational by August,” said HEXO CEO and co-founder, Sébastien St-Louis.

“We are confident we will be ready to fulfill our contract as the preferred supplier to the Société québécoise du cannabis (SQDC) and are excited to see what the future holds. These ongoing expansions, along with our innovative, high-quality products, put us in an optimal position as we continue discussions with other provincial authorities,” added Mr. St-Louis.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

Sign up to get the news alerts including the daily podcast and transcript for Investor ideas potcasts

Subscribe to the new cannabis podcast series:

Or visit


To hear more podcasts visit: podcasts are also available on iTunes, Google Play Music, Stitcher and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About - News that Inspires Big Ideas is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors. cannabis/marijuana and hemp content now includes on the news and stock directory pages, a cannabis investor group on , the 420 Cannabis Investor ideas, and the new AI site Global Cannabis Investing at

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info:

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: Global investors must adhere to regulations of each country.

Please read privacy policy:

To sponsor this podcast or be a guest



Marijuana / Hemp Stocks

Marijuana / Hemp Stocks at and

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Also check out our AI blog Global Cannabis Investing - features Investor Ideas Cannabis news